Keyword: General Electric
General Electric is selling its biomanufacturing operations to conglomerate Danaher for $21.4 billion.
GE is launching its prefab line of drug manufacturing units that will help biopharma companies produce viral vector-based vaccines.
Takeda-Zinfandel dropped an Alzheimer’s study; Shanghai Pharma will open an R&D site in the U.S.; NextCODE CEO talked about company plans.
Having won a couple of deals to build its prefabricated manufacturing facilities in Asia, GE will now invest €150 million to build out an entire campus in Ireland that will showcase its off-the-shelf technology.